Oméprazol
Pidangan
(dialihkeun ti Omeprazol)
Oméprazol nyaéta ubar anu umum digunakeun dina ngubaran panyakit refluks gastroesofagus (GERD), radang lambung atawa maag, radang anu pakait jeung panyakit Crohn, jeung sindrom Zollinger Elisson[1]. Omeprazol kagolong dina ubar jenis inhibitor pompa proton bareng jeung sababaraha ubar jiga lansoprazol jeung rabeprazol[2]
Oméprazol
| |
Ngaran sistimatik (IUPAC) | |
5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole | |
Identifiers | |
Nomer CAS | |
Sandi ATC | A02 |
PubChem | |
DrugBank | |
ChemSpider | |
Data kimia | |
Rumus | C17H19N3O3S |
Mass. mol. | 345.42 g/mol |
SMILES | & |
Data fisika | |
Titik lééh | 156 °C (313 °F) |
Data farmakokinetik | |
Bioavailabilitas | 35–76%[3][4] |
Ikatan protein | 95% |
Metabolisme | Hati (nganggo énzim CYP2C19, CYP3A4) |
Waktu paruh | 1–1.2 jam |
Eksresi | 80% (urin) 20% (feses) |
Therapeutic considerations | |
Licence data |
|
Kat. kehamilan | |
Legal status |
Prescription Only (S4)(AU) GSL(UK) OTC(US) |
Jalur | Oral, IV |
Galéri
[édit | édit sumber]-
Tablet oméprazol 20 mg
-
Vial injéksi oméprazol 20 mg
Rujukan
[édit | édit sumber]- ↑ "Omeprazole Monograph for Professionals". Drugs.com. Diakses tanggal 2020-04-30.
- ↑ Shin, Jai Moo; Sachs, George (2008-12-01). "Pharmacology of proton pump inhibitors" (dalam bahasa en). Current Gastroenterology Reports 10 (6): 528–534. doi:10.1007/s11894-008-0098-4. ISSN 1534-312X. PMC PMC2855237. PMID 19006606. https://doi.org/10.1007/s11894-008-0098-4.
- ↑ Prilosec Prescribing Information Archived 2010-02-16 di Wayback Machine. AstraZeneca Pharmaceuticals.
- ↑ Vaz-Da-Silva, M; Loureiro, AI; Nunes, T; Maia, J; Tavares, S; Falcão, A; Silveira, P; Almeida, L et al. (2005). "Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions". Clinical Drug Investigation 25 (6): 391–9. doi:10.2165/00044011-200525060-00004. PMID 17532679. http://www.medscape.com/viewarticle/508018.